ArticleJapanese journal of comprehensive rehabilitation science2025
The impact of pharmacist intervention on FIM gain in patients with musculoskeletal disorders in Kaifukuki rehabilitation wards.
Article in Japanese journal of comprehensive rehabilitation science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fujihara H, Kishimoto M, Kose E, Shinonaga H, Tanaka E, Nakamichi M, Mizokami F. The impact of pharmacist intervention on FIM gain in patients with musculoskeletal disorders in Kaifukuki rehabilitation wards. Jpn J Compr Rehabil Sci 2025; 16: 53-59. Objective: Currently, in Kaifukuki (convalescent) rehabilitation wards, pharmacists' services are not reimbursed under the medical fee system, which has hindered the placement of pharmacists in wards and made it difficult to fully clarify their usefulness. In this study, we classified patients with musculoskeletal disorders into groups that received active pharmacist intervention and those that did not, and evaluated the effect of pharmacist intervention on changes in ADL. Method: This was a multicenter retrospective cohort study targeting Kaifukuki rehabilitation wards. Participating hospitals were recruited through the website of the Japanese Society of Hospital Pharmacists. The study included patients with musculoskeletal disorders who were discharged from each participating hospital between October 1 and October 31, 2022. The primary outcome measure was FIM gain, which was compared between the active and non-intensive intervention groups. Results: Responses were received from 140 hospitals, and information was collected from 1,265 patients. After adjusting for propensity scores, 742 patients (371 in the active intervention group and 371 in the non-intensive intervention group) were included in the analysis. When comparing the FIM gains between the two groups, the active intervention group showed significantly higher values than the non-intensive intervention group. Discussion: Pharmacist intervention in patients with musculoskeletal disorders admitted to rehabilitation wards was significantly associated with improvements in ADL. Pharmacists working in Kaifukuki rehabilitation wards should actively participate in ward activities and contribute to the appropriate use of medications for hospitalized patients, including deprescribing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.